Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

/R E P E A T -- Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fields/

Canada NewsWire June 16, 2020

Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fields

Canada NewsWire June 16, 2020

/R E P E A T -- Sirona Biochem: Interview with Chief Scientific Officer Dr. Deliencourt-Godefroy on the Development Pipeline/

Canada NewsWire April 14, 2020

Sirona Biochem: Interview with Chief Scientific Officer Dr. Deliencourt-Godefroy on the Development Pipeline

Canada NewsWire April 14, 2020

/R E P E A T -- Sirona Biochem Initiates COVID-19 and Infectious Diseases Development Program/

Canada NewsWire March 31, 2020

Sirona Biochem Initiates COVID-19 and Infectious Diseases Development Program

Canada NewsWire March 31, 2020

The Top Healthcare Bullboards: Jan - Mar 2020

Stockhouse Editorial March 23, 2020

/R E P E A T -- Sirona Biochem: Letter to the Shareholders/

Canada NewsWire March 18, 2020

Sirona Biochem: Letter to the Shareholders

Canada NewsWire March 18, 2020

/R E P E A T -- Sirona Biochem Signs Letter of Intent with Top Chinese Pharmaceutical Development Company/

Canada NewsWire March 4, 2020

Sirona Biochem Signs Letter of Intent with Top Chinese Pharmaceutical Development Company

Canada NewsWire March 4, 2020

Sirona Biochem Announces Change of Auditor

Canada NewsWire February 14, 2020

/R E P E A T -- Sirona Biochem: 100% Safety in Final Tox Study for Increased Concentration of TFC-1067/

Canada NewsWire January 22, 2020

Sirona Biochem: 100% Safety in Final Tox Study for Increased Concentration of TFC-1067

Canada NewsWire January 22, 2020

Sirona Biochem Announces Grant of Stock Options

Canada NewsWire January 21, 2020

/R E P E A T -- Sirona Biochem CEO Letter to Shareholders/

Canada NewsWire December 19, 2019

Sirona Biochem CEO Letter to Shareholders

Canada NewsWire December 19, 2019

/R E P E A T -- Sirona Biochem Reports 100% Safety in First Tox Study for Increased Concentration of TFC-1067/

Canada NewsWire December 2, 2019

Sirona Biochem Reports 100% Safety in First Tox Study for Increased Concentration of TFC-1067

Canada NewsWire December 2, 2019

/R E P E A T -- Sirona Biochem Proceeds to First Clinical Tests for Higher Concentrations to Increase Commercial Value of Skin Lightening Compound TFC-1067/

Canada NewsWire October 30, 2019